Many patients feel entirely asymptomatic in daily life, yet neuroendocrine tumors are unexpectedly detected upon medical examination. At the mere sight of the word “tumor”, they are instantly overwhelmed by fear.

“Can tumors even grow on nerves? I’ve never heard of this condition!”“Is this disease terminal once diagnosed?”“All tumors are benign, right? Surgical removal will solve everything…”

Clinical Reminders from Physicians

Advancements in diagnostic technology have markedly boosted the detection rate of neuroendocrine tumors.Current incidence has risen eightfold compared with 20 years ago, with a growing number of young patients receiving diagnoses.

Basic Overview of Neuroendocrine Tumors

What Exactly Are Neuroendocrine Tumors?

Neuroendocrine tumors represent a heterogeneous group of neoplasms arising from peptidergic neurons and neuroendocrine cells.They can develop in any anatomical site across the human body, with the gastrointestinal tract, pancreas and lungs as the most common primary locations.

Who Belongs to High-Risk Populations?

Hereditary subtypes account for 5% to 10% of all neuroendocrine tumor cases.Individuals with a positive family history are therefore classified as high-risk groups and require close surveillance.

This does not mean patients without a family history are exempt from risk. In fact, over 90% of neuroendocrine tumors are sporadic and non-hereditary.

Furthermore, neuroendocrine tumors feature insidious onset with no definitive known etiology, leading to frequent misdiagnosis. Consequently, a large proportion of patients are only diagnosed at advanced stages.

Five Key Symptoms That Signal Neuroendocrine Tumors

The following manifestations may serve as warning signs of neuroendocrine tumors and warrant full vigilance:

1. Hypoglycemia accompanied by severe hunger pangs: Typically occurs in early morning or after physical activity, presenting with mild dizziness and vertigo.

2. Flushing: Sudden or persistent erythema of the face, head and torso, which may be triggered by alcohol intake, strenuous exercise, mental stress, or consumption of chocolate, bananas and other specific foods.

3. Diarrhea: Mild to moderate diarrhea often accompanied by abdominal pain.

4. Intermittent night sweats: Frequently misdiagnosed as menopausal symptoms.

5. Recurrent gastric ulcers: Presenting with abdominal pain, bloating and intermittent postprandial discomfort, commonly mistaken for stress bowel disorders or ordinary peptic ulcers.

Prompt medical consultation and screening for neuroendocrine tumors are mandatory if these symptoms recur repeatedly; do not delay evaluation.

Four Widespread Misconceptions About Neuroendocrine Tumors

Misconception 1: Neuroendocrine tumors are benign and curable via simple surgical resection

Upon seeing the term “tumor”, most people assume benign pathology. In reality, all neuroendocrine tumors carry malignant potential or are outright malignant, with risks of postoperative recurrence and metastasis.All patients require regular long-term follow-up and imaging surveillance after treatment.

Misconception 2: Neuroendocrine tumors are an incurable terminal illness

This represents the opposite extreme of misunderstanding.A wide array of effective therapeutic modalities is currently available. Early-stage neuroendocrine tumors achieve cure rates exceeding 90%. Even for incurable advanced cases, the average overall survival ranges from 5 to 10 years.

Neuroendocrine tumors are indolent neoplasms; early detection and intervention remain the core of successful management.

Misconception 3: Neuroendocrine tumors are diseases of the nervous system

This is completely incorrect.Despite the name containing “neuro-”, these tumors have no connection to neurological tissue whatsoever.Many patients mistakenly consult neurology or neurosurgery departments after receiving their reports, resulting in unnecessary delays to optimal treatment timing.

Misconception 4: Radiotherapy and chemotherapy are mandatory for neuroendocrine tumors

Numerous patients abandon treatment entirely out of fear of chemo- and radiotherapy. This perception is severely flawed.First-line management for neuroendocrine tumors centers on biotherapy and targeted therapy, with chemotherapy only indicated for a tiny subset of cases.Over 80% of metastatic neuroendocrine tumors require neither radiotherapy nor chemotherapy.

Preventive Strategies for Neuroendocrine Tumors

General asymptomatic populationHealthy individuals aged 45 and above are recommended to undergo annual physical examinations, including routine gastrointestinal endoscopy alongside standard screening panels.

Symptomatic populationSeek immediate comprehensive medical workup regardless of age if persistent discomfort lasts three months or longer, worsens progressively, and fails to improve with conventional symptomatic treatment.

In addition to regular disease screening, maintaining a healthy lifestyle and living environment serves as effective tumor prevention measures. Chronic heavy alcohol consumption and binge eating raise the risk of multiple malignancies, even aside from neuroendocrine tumors.

Standard Treatment Modalities for Confirmed Neuroendocrine Tumors

Patients diagnosed with neuroendocrine tumors need not be overly anxious, as diverse mature therapeutic options are now accessible beyond biotherapy and targeted therapy:

PET-CT: A specialized imaging modality for neuroendocrine tumor staging and assessment, featuring superior sensitivity and spatial resolution compared with conventional CT to detect tiny metastatic lesions.

Peptide Receptor Radionuclide Therapy (PRRT): Precisely targets and eliminates tumor cells with minimal damage to adjacent healthy normal tissue, suitable for both primary lesions and metastatic foci.

In summary, neuroendocrine tumors are relatively indolent malignancies. Do not allow unnecessary anxiety to delay your optimal treatment window.